GEODON PATENT EXPIRES ON March 2, 2012 !

Quote












The point is you will eventually have nothing to sell. Aricept LOE in a few months, I understand Viagra is months behind Lipitor and then you have Geodog in 2012. Help me Wyeth help me.
 












10% and bringing in a billion in much needed revenue. At least this dog was an in-house product. It sells itself, just ask the 10 different marketing teams that have been replaced over the past 8 years. Biggest joke was when we were aligned with Primary Care Manager's and RM's who thought simple messaging was all it took to sell. Talk about a giant step backward. Those were great do-nothing POA's! The people supporting that forward thinking were promoted - and the people against were "let go". Keep believing your own BS upper management, this game and your livelihood as well as ours will be extinct in 5 years. There are only so many times you idiots can reinvent the wheel as others at the management table watch on and shake there heads in agreement. Also, as a side note, when will you idiots in NY give us a new clinical for Geodon? Maybe you figured out it's not really going to change market share at this time in it's lifecycle, it should have been done 4 years ago. Love that Stahl paper! Mindless Idiots!
 
















The point is that this company is going down the tubes and the stock price is still in the toilet. And it will dip even lower after the next round of layoffs in November. Eventually Pfizer will be bought out or taken over and everyone, retirees, employees, everyone, will get screwed out of retirement, medical, you name it. It sucks but it's a fact.
 




So funny how upper mgmt thinks CUE is going to miraculously improve Geodon Mkt Share. Psychiatrists are STARVING for a new study of some kind. They are not idiots. They realize that these stupid CUE slides we are showing them are the same dumb old data from 1999. I don't care how good a salesman you are. Doctors lose respect for reps who pretend data from 10 yrs ago is new.

Earth to Mgmt: Instead of spending millions and millions on CUE, you should have invested in an SSRI Augmentation indication. Abilify is a horrible drug. How did they get more indications than Geodon when they entered the market several years later? Doctors don't even like Abilify. Yet they prescribe it 4X more than Geodon.

This is not rocket science.
Schiz represents 1% of atypical antipsychotic market. Bipolar 1 represents less than 5% of mkt.
Bipolar 2 + Tx refractory depression + Insomnia represent 70 - 90% of atypical mkt.

oh yea and we are BID, must be dosed w/ food, and have a bolded cardiovascular warning that nobody else has.
 




Anonymous said:
So funny how upper mgmt thinks CUE is going to miraculously improve Geodon Mkt Share. Psychiatrists are STARVING for a new study of some kind. They are not idiots. They realize that these stupid CUE slides we are showing them are the same dumb old data from 1999. I don't care how good a salesman you are. Doctors lose respect for reps who pretend data from 10 yrs ago is new.

Earth to Mgmt: Instead of spending millions and millions on CUE, you should have invested in an SSRI Augmentation indication. Abilify is a horrible drug. How did they get more indications than Geodon when they entered the market several years later? Doctors don't even like Abilify. Yet they prescribe it 4X more than Geodon.

This is not rocket science.
Schiz represents 1% of atypical antipsychotic market. Bipolar 1 represents less than 5% of mkt.
Bipolar 2 + Tx refractory depression + Insomnia represent 70 - 90% of atypical mkt.

oh yea and we are BID, must be dosed w/ food, and have a bolded cardiovascular warning that nobody else has.
Click to expand...

Who is starving for new data? Doctors? I think you mean YOU are. Data that's several years old doesn't suddenly become bad data. The real question is how long does the data stand up. Regarding less spending on CUE and more on new indications...did you ever think that maybe the drug just doesn't work in the same areas that other APs do? I'm thinking that some of the sales people need to look in the mirror. When is the last time you actually sold the drug's efficacy? Docs don't write AP's first line because they don't cause weight gain. Take a look at Siroquel. Drug couldn't be more sedating....but they use it b/c it's perceived to WORK. Same thing with Zyprexa. Despite major se's use it b/c they perceive it work!
 




Anonymous said:
So funny how upper mgmt thinks CUE is going to miraculously improve Geodon Mkt Share. Psychiatrists are STARVING for a new study of some kind. They are not idiots. They realize that these stupid CUE slides we are showing them are the same dumb old data from 1999. I don't care how good a salesman you are. Doctors lose respect for reps who pretend data from 10 yrs ago is new.

Earth to Mgmt: Instead of spending millions and millions on CUE, you should have invested in an SSRI Augmentation indication. Abilify is a horrible drug. How did they get more indications than Geodon when they entered the market several years later? Doctors don't even like Abilify. Yet they prescribe it 4X more than Geodon.

This is not rocket science.
Schiz represents 1% of atypical antipsychotic market. Bipolar 1 represents less than 5% of mkt.
Bipolar 2 + Tx refractory depression + Insomnia represent 70 - 90% of atypical mkt.

oh yea and we are BID, must be dosed w/ food, and have a bolded cardiovascular warning that nobody else has.
Click to expand...

CUE is a result of the JOD investigation and 2.3billion dollar settlement PFE paid out. CUE represents all sales reps using the same company provided / approved data and deviation from that you will be fired!
 




Anonymous said:
Who is starving for new data? Doctors? I think you mean YOU are. Data that's several years old doesn't suddenly become bad data. The real question is how long does the data stand up. Regarding less spending on CUE and more on new indications...did you ever think that maybe the drug just doesn't work in the same areas that other APs do? I'm thinking that some of the sales people need to look in the mirror. When is the last time you actually sold the drug's efficacy? Docs don't write AP's first line because they don't cause weight gain. Take a look at Siroquel. Drug couldn't be more sedating....but they use it b/c it's perceived to WORK. Same thing with Zyprexa. Despite major se's use it b/c they perceive it work!
Click to expand...

So kind of like despite your ignorance, management perceives you to work and be effective. Open your eyes, this is not like selling an antibiotic or a statin. Look, I'm not trying to make it sound like you have to be someone special to sell this dog, you just have to be intelligent in how to sell it. Pfizer doesn't believe in that logic anymore. Pfizer doesn't believe in the sales force anymore. Pfizer regards all in sales as a liability. Thanks for bringing us the baggage Warner Lambert (neurontin). Thanks for the additional baggage Pharmacia (celebrex/bextra). Thanks for opening up Pandora's Box Dr. McKinnel (OIG, Kindler, Sales Force's protracted death)
 




Siroquel ? are you kidding ? How many different DM's and RM's and DMT's have had to wake up to the fact that Geodon is not a "one size fits all" drug. It helps alot of people and has many areas for appropriate use but, "120-160mg by day two" is not the same thing as Prozac 20 or Lipitor 20 as it relates to blockbuster status.
 




I'm down in South West Florida and I have seen the negative side effects of this drug and it is horrible, mainly QT prolongation, and seizures. I actually think Abilify is much better, but don't tell anyone. Just tired of it all.
 




Anonymous said:
I'm down in South West Florida and I have seen the negative side effects of this drug and it is horrible, mainly QT prolongation, and seizures. I actually think Abilify is much better, but don't tell anyone. Just tired of it all.
Click to expand...

ABILIFY is much better, GEODON HAS THE TERRIBLE SIDE EFFECT AKATHISIA.
The akathisia side effect is why sales are slumping so much for GEODON.
 




Anonymous said:
GEODON never became a major blockbuster pill with only 1 billion in sales. It will have even more competition with generic RISPERDAL, SAPHRIS, and FANAPT entering the market.
Click to expand...

Ain't that the truth, GEODON is the suckiest antipsychotic on the market. It should try 4 billion in sales like SEROQUEL and ZYPREXA.
 




Anonymous said:
Try convincing all the DOCS on the West Coast of Florida to use this crap. What a joke glad it going away.
Click to expand...

I am in the same area and most of the psych docs are creeps. Most of them know that the product is garbage but I still put on my sock puppet and set up my magic trick table. Then if that doesn't work I break out the boom box and and portable stripper pole and dance for them. Grab my signatures and I'm out there. I am one hell hell of sales person.
 




Top Bottom
Back
Quote